Desvenlafaxine ER Tabs 50mg

Manufacturer RANBAXY Active Ingredient Desvenlafaxine(des ven la FAX een) Pronunciation des ven la FAX een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Feb 2008
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Desvenlafaxine is an antidepressant medication that works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. It is used to treat major depressive disorder, helping to improve mood, sleep, appetite, and energy levels.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, but be sure to swallow the tablet whole with a fluid. Do not chew, break, crush, or dissolve the tablet.

Take your medication at the same time every day to establish a routine. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Keep all medications in a safe location, out of the reach of children and pets. When your medication is no longer needed or has expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. If you have questions about disposing of your medication, ask your pharmacist. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Take the medication exactly as prescribed, usually once daily with or without food. Do not crush, chew, or divide the extended-release tablet.
  • Do not stop taking desvenlafaxine suddenly without consulting your doctor, as this can lead to withdrawal symptoms (e.g., dizziness, nausea, headache, anxiety). Your doctor will guide you on how to slowly reduce the dose if discontinuation is necessary.
  • Avoid or limit alcohol consumption while taking this medication, as it can worsen side effects.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it may cause dizziness or drowsiness.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking, especially St. John's Wort, other antidepressants, triptans for migraines, or blood thinners.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 50 mg orally once daily
Dose Range: 50 - 100 mg

Condition-Specific Dosing:

Major Depressive Disorder: 50 mg orally once daily. Doses above 50 mg/day have not been shown to provide additional benefit and may increase adverse reactions.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established; increased risk of suicidal thoughts and behavior in clinical trials for other antidepressants)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed (CrCl 50-70 mL/min)
Moderate: 50 mg every other day (CrCl 30-49 mL/min)
Severe: 50 mg every other day (CrCl <30 mL/min)
Dialysis: 50 mg twice weekly, administered after dialysis session. Do not administer on dialysis days.

Hepatic Impairment:

Mild: No dosage adjustment needed
Moderate: 50 mg once daily
Severe: 50 mg every other day

Pharmacology

πŸ”¬

Mechanism of Action

Desvenlafaxine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI). It enhances the neurotransmission of serotonin and norepinephrine in the central nervous system by blocking their reuptake into presynaptic neurons. This leads to increased concentrations of these neurotransmitters in the synaptic cleft, which is thought to contribute to its antidepressant effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 80%
Tmax: Approximately 7.5 hours (range 6.5-8.5 hours)
FoodEffect: Food has minimal effect on Cmax or AUC of desvenlafaxine.

Distribution:

Vd: Approximately 3.4 L/kg
ProteinBinding: Approximately 30% (primarily to albumin and alpha-1 acid glycoprotein)
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 10-12 hours
Clearance: Approximately 15.5 L/h
ExcretionRoute: Renal (primarily)
Unchanged: Approximately 45% of the administered dose is excreted unchanged in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Typically 1-2 weeks for initial therapeutic effects; full antidepressant effect may take 4-6 weeks.
PeakEffect: 4-6 weeks for full therapeutic effect.
DurationOfAction: 24 hours (due to extended-release formulation and half-life).

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thoughts and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Desvenlafaxine is not approved for use in pediatric patients. Closely monitor all antidepressant-treated patients for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial few months of treatment or when the dose is changed.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of low sodium levels: headache, difficulty focusing, memory problems, confusion, weakness, seizures, or changes in balance.
Signs of bleeding: vomiting or coughing up blood, vomit that resembles coffee grounds, blood in the urine, black, red, or tarry stools, bleeding from the gums, abnormal vaginal bleeding, unexplained bruises or bruises that enlarge, or uncontrollable bleeding.
Signs of high blood pressure: severe headache or dizziness, fainting, or changes in vision.
Signs of lung or breathing problems: shortness of breath or other breathing difficulties, cough, or fever.
Chest pain or pressure.
Seizures.
Hallucinations (seeing or hearing things that are not real).
Sex-related problems, including decreased interest in sex, difficulty having an orgasm, ejaculation problems, or trouble achieving or maintaining an erection. If you have concerns, discuss them with your doctor.
A potentially life-threatening condition called serotonin syndrome may occur, especially if you are taking certain other medications. Seek immediate medical attention if you experience agitation, changes in balance, confusion, hallucinations, fever, rapid or abnormal heartbeat, flushing, muscle twitching or stiffness, seizures, shivering or shaking, excessive sweating, severe diarrhea, stomach upset, or vomiting, or a severe headache.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they persist, contact your doctor or seek medical attention:

Dizziness, drowsiness, fatigue, or weakness.
Upset stomach or vomiting.
Constipation.
Dry mouth.
Difficulty sleeping.
Decreased appetite.
Sweating.
Shakiness.

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of Serotonin Syndrome: Agitation, confusion, rapid heart rate, fever, sweating, muscle stiffness or twitching, uncontrolled movements, nausea, vomiting, diarrhea. Seek immediate medical attention.
  • Worsening depression, suicidal thoughts or behavior, or unusual changes in mood or behavior (e.g., new or worsening anxiety, panic attacks, irritability, aggression, restlessness, insomnia, impulsivity, mania). Contact your doctor immediately.
  • Unusual bleeding or bruising, including nosebleeds, bleeding gums, or blood in stool/urine.
  • New or worsening high blood pressure.
  • Symptoms of hyponatremia (low sodium): Headache, confusion, weakness, unsteadiness, memory problems, or seizures. Seek medical attention.
  • Eye pain, changes in vision, or swelling or redness in or around the eye (may indicate angle-closure glaucoma).
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
A diagnosis of narrow-angle glaucoma.
High blood pressure.
Current or recent use of certain medications, including:
+ Linezolid or methylene blue.
+ Drugs for depression or Parkinson's disease taken within the last 14 days, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to very high blood pressure.
Use of another medication that contains the same active ingredient as this drug.
Use of a similar medication, if you are unsure, consult your doctor or pharmacist.

This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems, to your doctor and pharmacist. This will help determine the safety of taking this medication with your other treatments. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. The full effects of this drug may not be apparent for several months.

To ensure your safety, avoid driving and other activities that require alertness until you understand how this medication affects you. When changing positions, such as standing up from a sitting or lying down position, do so slowly to minimize the risk of dizziness or fainting. Be cautious when navigating stairs.

Do not abruptly stop taking this medication without consulting your doctor, as this may increase your risk of experiencing side effects, which can be severe and long-lasting. If you need to discontinue this medication, your doctor will provide guidance on how to gradually stop taking it. If you experience any new or worsening symptoms, discuss them with your doctor promptly.

This medication may cause high blood pressure, so it is crucial to have your blood pressure monitored as directed by your doctor. Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or other prescription or over-the-counter medications that may cause drowsiness, consult with your doctor.

There is a potential increased risk of bleeding associated with this medication, which can be life-threatening in some cases. Discuss this risk with your doctor. Some individuals may have a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye examination to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may cause low blood sodium levels, which can be fatal in severe cases. Discuss this risk with your doctor. Additionally, high cholesterol has been reported in individuals taking this medication. If you have concerns, consult with your doctor.

This medication may affect the results of certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication. If you notice what appears to be a tablet in your stool, do not be alarmed, as this is a normal occurrence and not a cause for concern. If you have questions, discuss them with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor. Taking this medication during the third trimester of pregnancy may increase the risk of bleeding after delivery and potentially cause health problems in the newborn. Your doctor will discuss the benefits and risks of taking this medication during pregnancy and breastfeeding.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Tachycardia (rapid heart rate)
  • Somnolence (drowsiness)
  • Mydriasis (dilated pupils)
  • Vomiting
  • ECG changes (e.g., QTc prolongation, bundle branch block)
  • Seizures
  • Hypertension or hypotension
  • Serotonin syndrome (in severe cases)

What to Do:

Seek immediate medical attention or call Poison Control (1-800-222-1222). Treatment is generally supportive and symptomatic. Ensure adequate airway, oxygenation, and ventilation. Activated charcoal may be considered if administered soon after ingestion. Monitor cardiac rhythm and vital signs. There is no specific antidote.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs): Concomitant use or within 14 days of discontinuing an MAOI, or initiating an MAOI within 7 days of discontinuing desvenlafaxine, due to risk of serotonin syndrome.
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, other SNRIs, triptans, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort): Increased risk of serotonin syndrome.
  • Anticoagulants (e.g., warfarin) and antiplatelet agents (e.g., aspirin, NSAIDs): Increased risk of bleeding, including gastrointestinal bleeding.
🟑

Moderate Interactions

  • Drugs that increase blood pressure or heart rate (e.g., sympathomimetics): Potential for additive effects.
  • Alcohol: May potentiate CNS effects and increase risk of liver toxicity (though desvenlafaxine metabolism is not hepatic CYP-dependent, general caution with CNS depressants).
🟒

Minor Interactions

  • Not many specific minor interactions due to minimal CYP450 metabolism.

Monitoring

πŸ”¬

Baseline Monitoring

Depression/Anxiety Severity

Rationale: To establish baseline symptoms and track treatment response.

Timing: Prior to initiation

Blood Pressure and Heart Rate

Rationale: SNRIs can cause dose-dependent increases in blood pressure and heart rate.

Timing: Prior to initiation

Weight

Rationale: To monitor for significant weight changes.

Timing: Prior to initiation

Suicidal Ideation/Behavior

Rationale: Antidepressants carry a black box warning for increased risk of suicidality in young adults.

Timing: Prior to initiation

Serum Sodium

Rationale: To assess baseline for hyponatremia risk, especially in elderly or those on diuretics.

Timing: Prior to initiation (consider in at-risk patients)

πŸ“Š

Routine Monitoring

Blood Pressure and Heart Rate

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Maintain within normal limits or patient's baseline.

Action Threshold: Significant or sustained increases warrant dose adjustment or alternative therapy.

Mood and Suicidal Ideation

Frequency: Weekly during initial treatment (first few months) and dose changes, then periodically.

Target: Improvement in mood, absence of suicidal thoughts.

Action Threshold: Worsening depression, emergence of suicidal thoughts, or unusual behavioral changes require immediate assessment and intervention.

Weight

Frequency: Periodically (e.g., every 3-6 months).

Target: Maintain stable weight.

Action Threshold: Significant or rapid weight gain/loss.

Serum Sodium

Frequency: Periodically, especially in elderly, volume-depleted, or those on diuretics.

Target: 135-145 mEq/L

Action Threshold: Hyponatremia (<135 mEq/L) requires investigation and potential discontinuation.

Bleeding/Bruising

Frequency: Ongoing patient education and inquiry.

Target: Absence of unusual bleeding.

Action Threshold: Unexplained bruising, petechiae, or signs of GI bleeding (e.g., melena) require investigation.

πŸ‘οΈ

Symptom Monitoring

  • Serotonin Syndrome (agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, nausea, vomiting, diarrhea)
  • Withdrawal Symptoms (dizziness, nausea, headache, irritability, insomnia, anxiety, paresthesia, fatigue, flu-like symptoms) upon abrupt discontinuation
  • Worsening depression or emergence of suicidal thoughts/behavior
  • Unusual bleeding or bruising
  • New or worsening hypertension
  • Signs of hyponatremia (headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, falls; severe: hallucinations, syncope, seizures, coma, respiratory arrest)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Exposure during the third trimester may lead to complications in the neonate, including withdrawal symptoms and persistent pulmonary hypertension of the newborn (PPHN).

Trimester-Specific Risks:

First Trimester: Limited data, but generally not associated with major congenital malformations.
Second Trimester: Limited data.
Third Trimester: Risk of neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, persistent crying) and persistent pulmonary hypertension of the newborn (PPHN).
🀱

Lactation

Desvenlafaxine is excreted into breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for desvenlafaxine, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition.

Infant Risk: Monitor breastfed infants for sedation, poor feeding, and poor weight gain. The relative infant dose (RID) is generally low, suggesting a low risk, but individual infant sensitivity varies.
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Antidepressants, including desvenlafaxine, increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (aged 18-24) compared to placebo in short-term studies.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness were observed between geriatric and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for hyponatremia and falls. Dosage adjustments may be necessary based on renal function, which often declines with age.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Desvenlafaxine is the major active metabolite of venlafaxine, but it has a more favorable pharmacokinetic profile (longer half-life, less CYP interaction).
  • The extended-release tablet should be swallowed whole; do not crush, chew, or divide. The tablet shell may be excreted in the stool, which is normal and does not mean the medication was not absorbed.
  • Due to its minimal CYP450 metabolism, desvenlafaxine may be a preferred SNRI for patients on multiple medications with potential CYP interactions.
  • Abrupt discontinuation can lead to significant withdrawal symptoms (discontinuation syndrome); taper dose gradually over at least 1-2 weeks, or longer if symptoms emerge.
  • Monitor blood pressure regularly, especially during initial treatment and dose increases, as dose-dependent increases in blood pressure can occur.
  • Consider baseline and periodic serum sodium monitoring, particularly in elderly patients or those at risk for hyponatremia.
πŸ”„

Alternative Therapies

  • Other SNRIs (e.g., venlafaxine, duloxetine, levomilnacipran)
  • SSRIs (e.g., escitalopram, sertraline, fluoxetine, paroxetine, citalopram)
  • Atypical antidepressants (e.g., bupropion, mirtazapine, vortioxetine, vilazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, nortriptyline)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $30-$150 per 30 tablets (50mg)
Generic Available: Yes
Insurance Coverage: Often Tier 1 or Tier 2 for generic; Tier 3 or higher for brand.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information about your treatment. Please read this guide carefully and review it again whenever you receive a refill of your medication. If you have any questions or concerns about your medication, don't hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, it's crucial to seek immediate medical attention. Call your local poison control center or visit the emergency room right away. When seeking help, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount consumed, and the time it occurred.